CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
Impact Grant - Chordoma Foundation supports researchers pursuing preclinical and translational chordoma immunology projects to explore new immunotherapy approaches and accelerate research in this disease.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
Clinical Innovator Award supports researchers conducting early-phase immunotherapy trials in chordoma, funding clinical investigation to move promising concepts toward potential patient impact.
CRI Technology Impact Award supports technology developers and clinical cancer immunologists in creating unbuilt, untested technologies to overcome barriers and enable more effective cancer immunotherapies.
CRI Clinic and Laboratory Integration Program supports investigator teams translating cancer immunology discoveries into immune-based approaches to prevent initial cancer development and recurrence.